Form 4 for AEON AEON Biopharma, Inc.

Accepted 2026-03-05 00:00:00 ET · period of report 2026-02-17 · accession 0001104659-26-024233 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2026-03-05	2026-02-17+	AEON	Wilson Alexander Blair	CLO, CSO, Corp Sec	A - Grant	$0.00	+2.18M	2.18M	+59,988%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2026-02-17	A	A	862,500	$0.00	866,133	D	—	—	(F1) Represents an award of restricted stock units granted on February 17, 2026 (the "Grant Date"), which vest in substantially equal installments on each of the first, second, third and fourth anniversary of the Grant Date, subject to continued service through the applicable vesting date.
2	Common	Class A Common Stock	2026-03-04	A	A	1,316,872	$0.00	2,183,005	D	—	—	(F2) Represents outstanding cash-settled restricted stock units granted on May 21, 2025 (the "Grant Date") that were modified on March 4, 2026 to be settled in stock instead of cash upon vesting. The restricted stock units continue to vest in substantially equal installments on each of the first, second, third and fourth anniversary of the Grant Date, subject to continued service through the applicable vesting date. The restricted stock units were originally reported in Table II on a Form 4 filed on May 23, 2025.